Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice

Gene Ther. 2000 Sep;7(17):1447-57. doi: 10.1038/sj.gt.3301261.

Abstract

Intramuscular administration of plasmid expressing full-length human dystrophin in dystrophin-deficient adult mdx mice resulted in humoral and weak specific T cell responses against the human dystrophin protein. Following plasmid injection, human dystrophin was detected in the injected muscles at 7 days, but decreased thereafter. Anti-dystrophin antibodies were found 21 days following plasmid injection, which coincided with transient myositis. This immune rejection prevented the mice from expressing human dystrophin after a second plasmid injection. No anti-DNA antibodies were found. Anti-dystrophin antibodies were seen in a smaller proportion of plasmid-injected dystrophin-competent C57BL/10 mice, suggesting that the immune rejection of dystrophin may be explained partially by species differences in the dystrophin protein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies / analysis*
  • Blotting, Western / methods
  • Dystrophin / analysis
  • Dystrophin / genetics*
  • Dystrophin / immunology
  • Enzyme-Linked Immunosorbent Assay / methods
  • Genetic Therapy / adverse effects*
  • Genetic Therapy / methods
  • Humans
  • Immunohistochemistry / methods
  • Injections, Intramuscular
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred mdx
  • Muscle, Skeletal / chemistry
  • Muscle, Skeletal / immunology
  • Muscular Dystrophy, Duchenne / immunology
  • Muscular Dystrophy, Duchenne / therapy*
  • Plasmids / administration & dosage*
  • Species Specificity
  • T-Lymphocytes / immunology*

Substances

  • Antibodies
  • Dystrophin